Skip to content

ImmunityBio

US · IBRX #1397 by market cap Listed 1970
6.02 -0.55 -8.37%
Periodic snapshot; not a real-time feed. · 2026-11-20 19:59

✦ Quant Ownership Signal how this is computed

Accumulating
  • The number of reporting institutions increased by 10 in the most recent period (2026/Q3).
  • Total institutional ownership (as a % of shares) was little changed.

Ownership vs. money flow

Aligned

Institutions trimmed shares last reporting period, and the stock has seen net outflows in main-fund flow over the last 20 trading sessions - the two line up.

Institutional ownership changes are reported quarterly with a lag; fund-flow data is daily. Treat this as a directional cross-check, not a precise timing signal.

Institutional ownership

Held by institutions
53.29% -0.05pp
Institutions
459 +10
As of
2026/Q3 vs. prior period

Holder types

Individual/Insider27.79%
VC/PE Fund24.35%
Mutual Fund14.61%
Private Company9.51%
Hedge Fund3.43%
Public Company1.03%
Government Pension Fund0.17%
Family Office/Trust0.11%
Other18.93%

Top holders as of 2026-07-31

Patrick Soon-Shiong 27.40% · 291.46M sh
California Capital Equity, LLC 24.35% · 259.00M sh
NantWorks, LLC 9.26% · 98.54M sh
BlackRock 3.40% · 36.12M sh
State Street Global Advisors 1.99% · 21.10M sh
Vanguard Portfolio Management, LLC 1.82% · 19.39M sh
Vanguard Capital Management, LLC 1.77% · 18.80M sh
D. E. Shaw & Co., L.P. 1.09% · 11.55M sh
Two Sigma Investments, LP 1.04% · 11.10M sh
Geode Capital Management, LLC 1.00% · 10.61M sh

Bar length is relative to the largest holder shown here, not to 100% of the company.

Insiders

50 filings tracked · 21 buys · 29 sells

NameRoleStake
Patrick Soon-Shiong Founder, Executive Chairman and Global Chief Scientific & Medical Officer 27.40%
California Capital Equity, LLC -- 24.35%
Barry Simon Chief Corporate Affairs Officer & Director 0.26%
Richard Adcock Chief Executive Officer 0.05%
David Sachs Chief Financial Officer 0.03%
Michael Blaszyk Independent Director 0.02%
Regan Lauer Chief Accounting Officer 0.01%
Cheryl Cohen Lead Independent Director 0.01%
John Brennan Former Independent Director 0.00%
Wesley Clark Independent Director 0.00%

Insider transactions most recent Form 4 filings

DateNameRoleTypeSharesPrice
2026-10-04 Barry Simon Chief Corporate Affairs Officer & Director Automatic Disposition -25,000 $10.75
2026-10-04 Barry Simon Chief Corporate Affairs Officer & Director Intent to Sell (Form 144) -560,000 $13.67
2026-10-01 Cheryl Cohen Lead Independent Director Automatic Disposition -25,077 $10.50
2026-10-01 Cheryl Cohen Lead Independent Director Derivative Exercise and Sale -55,979 $2.98–10.50
2026-07-01 Cheryl Cohen Lead Independent Director Automatic Disposition -75,231 $9.50
2026-07-01 Cheryl Cohen Lead Independent Director Derivative Exercise and Sale -55,979 $2.98–9.50
2026-06-30 Christobel Selecky Independent Director Derivative Exercise and Sale -159,478 $2.98–9.02
2026-06-29 Christobel Selecky Independent Director Derivative Exercise and Sale -96,722 $2.84–9.01
2026-06-29 Christobel Selecky Independent Director Intent to Sell (Form 144) -1,000 $8.77
2026-06-28 Christobel Selecky Independent Director Intent to Sell (Form 144) -95,722 $8.71
2026-06-23 Barry Simon Chief Corporate Affairs Officer & Director Automatic Disposition -25,000 $7.88
2026-06-08 Christobel Selecky Independent Director Other Derivative Acquisition +65,600 $7.25
2026-06-08 Wesley Clark Independent Director Other Derivative Acquisition +65,600 $7.25
2026-06-08 Bruce Wendel Independent Director Other Derivative Acquisition +65,600 $7.25
2026-06-08 Michael Blaszyk Independent Director Other Derivative Acquisition +65,600 $7.25
2026-06-08 Cheryl Cohen Lead Independent Director Other Derivative Acquisition +65,600 $7.25
2026-06-08 Linda Maxwell Independent Director Other Derivative Acquisition +65,600 $7.25
2026-06-03 Barry Simon Chief Corporate Affairs Officer & Director Automatic Disposition -23,033 $7.18
2026-03-30 California Capital Equity, LLC -- Derivative Exercise and Retained +4,606,596 $5.43
2026-02-23 Barry Simon Chief Corporate Affairs Officer & Director Automatic Disposition -75,000 $12.01

Form 4 filings, most recent per company. "Other Derivative Acquisition" rows are mostly RSU/option vesting, not open-market buying - the Type column says which.

Quote time 2026-11-20 19:59:40 · For reference only, not investment advice and not tailored to your situation.

ImmunityBio discussion 0 comments

Add a comment